期刊文献+

50L罐头孢菌素C发酵过程豆油流加控制策略的优化

Optimization of soybean oil feeding strategy for cephalosporin C fermentation conducted in 50L bioreactor
下载PDF
导出
摘要 目的优化头孢菌素C(CPC)发酵过程的豆油补料控制策略,提高发酵整体性能。方法提出了一种匀速+DO-Stat结合型补油策略。在50L罐上对使用该策略和使用匀速补油以及传统DO-Stat自动补油策略的发酵性能进行比较,确定最优补油控制策略。结果采用匀速+DO-Stat结合型补油策略时,CPC终浓度最高,CPC得率也从使用匀速补油策略时的19.61%提高到25.74%,代谢主副产物去乙酰氧头孢菌素C(DAOC)的积累量少,DAOC/CPC(W/W)只有0.46%,达到生产要求。结论使用匀速+DO-Stat结合型补油策略,可控制CPC发酵过程中的碳源浓度和溶解氧浓度(DO)于合适水平,在维持较高的CPC生产强度的前提下,CPC得率大幅提高,代谢副产物的积累得到抑制、产品质量得到控制。 Objective Optimizing soybean oil feeding strategy to improve the overall cephalosporin C (CPC) fermentation performance. Methods A novel and automatic soybean oil feeding strategy combining constant feeding and DO-Stat feeding (constant+DO-Stat feeding) was proposed and applied in CPC fermentation in 50L bioreactor. Fermentation performance utilizing different soybean oil feeding strategies, namely, constant feeding, DO-Stat based feeding and the proposed constant+DO-Stat feeding was compared, and the optimal feeding strategy was determined. Results When using the constant+DO-Stat feeding strategy, final CPC concentration was the highest; CPC yield was largely increased from 19.50% when adopting the constant feeding strategy to 25.74%; less deacetoxycephalosporin C (DAOC), the major by-product of CPC fermentation, was accumulated; DAOC/CPC (W/W) stayed at low level of 0.46% satisfying with the industrial standard. Conclusion The newly proposed constant+DO-Stat feeding strategy could control both carbon source concentration and DO at adequate levels simultaneously, CPC yield was largely increased and DAOC accumulation was significantly repressed, while CPC productivity was maintained at comparably high level.
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2013年第7期501-506,共6页 Chinese Journal of Antibiotics
基金 国家科技支持计划(No.2007BAI26B02) 国家973项目(No.2007CB714303)
关键词 豆油 头孢菌素C DO-Stat 流加策略 发酵 Soybean oil Cephalosporin C DO-Stat Feeding strategy Fermentation
  • 相关文献

参考文献15

  • 1牛维兵,许朴勤,王静.头孢菌素C的分离研究进展[J].河北化工,2007,30(10):38-39. 被引量:3
  • 2薛雨,陈宇瑛.头孢菌素类抗生素的最新研究进展[J].中国抗生素杂志,2011,36(2):86-92. 被引量:92
  • 3Adinarayana K, Prabhakar T, Srinivasulu V, et al. Optimization of process parameters for cephalosporin C production under solid state fermentation from Acremonium chrysogenum[J]. Process Biochem, 2003, 39(2): 171-177.
  • 4Demain A 1. Biosynthesis of cephalosporins in "Developmemts in Idustrial Microbiology" [J]. Ed G pierce, 1987, 27: 175-182.
  • 5Jekosch L, Kiick U. Glucose dependent transcriptional expression of the crel gene in Acremonium chrysogenum strains showing different levels of cephalosporin Cproduction[J]. Curr Genet, 2000, 37(6): 388-395.
  • 6Behmer C J, Demain A L. Further Studies on Carbon Catabolite Regulation of 13-Lactam Antibiotic Synthesis in Cephalosporium acremonium[J]. Current Microbiol, 1983, 8 (2): 107-114.
  • 7Jekosch K, Kiick U. Loss Acremonium chrysogenum of glucose repression in an I-lactam producer strain and its restoration by multiple copies of the crel gene[J]. Appl Microbiol Biot, 2000, 54(4): 556-563.
  • 8Ortiz S C A, Hokka C O, Badino A C. Utilization of soybean derivatives on clavulanic acid production by Streptomyces clavuligerus[J]. Enzyme Microb Tech, 2007, 40(5): 1071-1077.
  • 9Hsieh C , Liu C J, Tseng M H, et al. Effect of olive oil on the production of mycelial biomass and polysaccharides of Grifola frondosa under high oxygen concentration aeration[J]. Enzyme Microb Tech, 2006, 39(3): 434-439.
  • 10Revin W, Kasatkin S A, Cherkasova G N, et al. Effect of the quality of fat substrate on the dynamics of fatty acid utilization during biosynthesis of cephalosporin C[J]. .4ntibiot Khimioter, 1991, 36(1): 5-8.

二级参考文献40

  • 1万平,冀志霞,储炬,庄英萍,张嗣良,罗家立,白骅.菌丝形态分化与头孢菌素C合成的关系[J].微生物学通报,2005,32(1):15-21. 被引量:10
  • 2曹云峰,鲍建芝,吴兆亮,张晓艳,董荣梅.头孢菌素C钠溶液膜超滤分离工艺的研究[J].河北化工,2005,28(3):59-61. 被引量:1
  • 3张致平.抗生素结构修饰的进展[J].中国抗生素杂志,2006,31(2):90-99. 被引量:9
  • 4刘家健.头孢菌素类品种研发与生产现状探讨[J].中国抗生素杂志,2006,31(2):100-106. 被引量:17
  • 5Jack J C, Theresa M B, Joseph T W, et al. Randomized, prospective comparison of first-and second-generation cephalosporins as infection prophylaxis for cardiac surgery[J]. Am JSurg, 1993, 166(6): 734-737.
  • 6Stuart M H. Pharmacokinetics of the third-generation cephalosporins[J]. Am J Med, 1985, 79(2): 21-24.
  • 7Emirhan N, Sedef K, Doruk K, et al. Simultaneous roultiresponse optimization of an HPLC method to separate seven cephalosporins in plasma and amniotic fluid: Application to validation and quantification of cefepime, cefixime and cefoperazone[J]. Talanta, 2009, 80(1): 117-126.
  • 8Yoshizawa H, Kubota T, Itani H, et al. New broad-spectrum parenteral cephalosporins exhibiting potentactivity against both methicillin-resistant Staphylococcus aureus(MRSA ) and Pseudomonas aeruginosa. Part 2: Synthesis and Structure-activity relationships in the S-3578 series[J]. Bioorg Med Chem, 2004, 12:4211-4219.
  • 9Gasink L B, Fishrnan N O, Weiner M G, et al. Fluoroquinolone- resistant Pseudomonas aeruginosa: assessment of risk factors and clinical impact[J]. Am JMed, 2006, 119(6): 526.
  • 10Tomoyasu I, Shohei H, Yuj I. Phosphonocephem derivatives, process for the preparation of the same and use thereof [P]. US 6417175 B1, 2006-07-09.

共引文献130

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部